Seaport announced the presentation of additional data from its first-in-human, multi-part Phase 1 study of SPT-300 in healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback